Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA Share Price    (GLPH)

Here is the latest stock price and chart of Glenmark Pharma. For more details, see the Glenmark Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

#1 Small-Cap Stock: Biggest Opportunity in the Indian FMCG Market

REFRESH
Live BSE Quotes Sep 21, 2020 03:35:00 PM
Price (Rs)474.00 Open (Rs) 509.00 High (Rs) 513.75 Low (Rs) 461.75
% Change-6.81 Volume 324,101 Value (Rs) 153,623,874 52-Week H/L 572.70 / 168.00
Live NSE Quotes Sep 21, 2020 3:29:59 PM
Price (Rs)475.00 Open (Rs) 508.00 High (Rs) 514.00 Low (Rs) 461.50
% Change-6.66 Volume 4,133,654 Value (Rs) 2,030,492,181 52-Week H/L 573.05 / 161.65
Change
1 Day
-6.81%
1 Month
-3.64%
3 Months
-8.81%
1 Year
34.72%
5 Years (CAGR)*
-14.25%
10 Years (CAGR)*
5.15%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 32.63 P/E Ratio (x) 14.53 Market Cap (Rs m) 133,747.63 P/BV (x) 2.39
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

GLENMARK PHARMA Share Price Today:

GLENMARK PHARMA last traded price had tanked 6.8% to Rs 474.0 on the BSE. On the NSE, GLENMARK PHARMA last traded price had tanked 6.7% to Rs 475.0. The total volume of shares traded was 4.5 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 3.9%. And the benchmark S&P BSE SENSEX was at 38,034.1 (down 2.1%).

Over the last 30 days, the GLENMARK PHARMA share price is down 1.4%. And over the last one year, GLENMARK PHARMA share price is up 28.0%.



What else is happening in the markets today? Dig in...


Today's Market

Sensex Crashes 812 Points on Global Selloff; Telecom, Realty and Metal Stocks Bleed(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red, tracking weak global cues.

Related Views On News

GLENMARK PHARMA Share Price Down by 5%; BSE HEALTHCARE Index Down 2.3% (Market Updates)

Sep 21, 2020 | Updated on Sep 21, 2020

GLENMARK PHARMA share price is trading down by 5% and its current market price is Rs 514. The BSE HEALTHCARE is down by 2.3%. The top gainers in the BSE HEALTHCARE Index are APOLLO HOSPITALS (up 1.3%) and ASTRAZENECA PHARMA (up 1.3%). The top losers is GLENMARK PHARMA (down 5.0%)..

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why am I Recommending Caution? (Fast Profits Daily)

Sep 9, 2020

This is why I have changed my short-term view on the market.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 5-YR ANALYSIS

COMPARE GLENMARK PHARMA WITH

MARKET STATS